Published in Brain Behav Immun on August 06, 2011
Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology (2012) 1.69
Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry (2014) 1.18
Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain (2013) 1.13
Brain morphology links systemic inflammation to cognitive function in midlife adults. Brain Behav Immun (2015) 0.88
Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship. Neurocase (2012) 0.86
Regional brain shrinkage over two years: individual differences and effects of pro-inflammatory genetic polymorphisms. Neuroimage (2014) 0.85
Rivastigmine is associated with restoration of left frontal brain activity in Parkinson's disease. Mov Disord (2013) 0.83
Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review. Clin Pharmacol Ther (2014) 0.82
Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Alzheimers Res Ther (2015) 0.81
Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. Brain Behav Immun (2015) 0.81
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset. Schizophr Bull (2016) 0.81
Inflammation and cognitive functioning in African Americans and Caucasians. Int J Geriatr Psychiatry (2014) 0.80
Combination therapies: The next logical Step for the treatment of synucleinopathies? Mov Disord (2015) 0.79
Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration. JAMA Neurol (2016) 0.78
Omega-3 fatty acids moderate effects of physical activity on cognitive function. Neuropsychologia (2014) 0.78
Effect of preoperative statin therapy on early postoperative memory impairment after off-pump coronary artery bypass surgery. Ann Card Anaesth (2016) 0.77
Cognitive Changes during Prolonged Stay at High Altitude and Its Correlation with C-Reactive Protein. PLoS One (2016) 0.77
Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase (2015) 0.76
Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline. Front Aging Neurosci (2016) 0.75
Interaction between C-reactive protein and cognitive functions according to APOE gene polymorphism in post-menopausal women. Arch Med Sci (2016) 0.75
Peripheral inflammation related to lower fMRI activation during a working memory task and resting functional connectivity among older adults: a preliminary study. Int J Geriatr Psychiatry (2016) 0.75
National Economic Development Status May Affect the Association between Central Adiposity and Cognition in Older Adults. PLoS One (2016) 0.75
The Immunomodulatory Effects of Plant Extracts and Plant Secondary Metabolites on Chronic Neuroinflammation and Cognitive Aging: A Mechanistic and Empirical Review. Front Pharmacol (2017) 0.75
Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population. Brain Behav Immun (2017) 0.75
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage (1999) 29.82
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
The medial temporal lobe. Annu Rev Neurosci (2004) 11.98
Sequence-independent segmentation of magnetic resonance images. Neuroimage (2004) 11.36
A hybrid approach to the skull stripping problem in MRI. Neuroimage (2004) 9.59
Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging (2001) 8.14
Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66
Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology (2002) 5.40
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004) 4.73
Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging (2007) 4.18
Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol (2002) 3.54
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev (1995) 3.05
Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus (1999) 3.00
Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology (2002) 2.68
Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun (2002) 2.29
Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology (2010) 2.21
Serum inflammatory proteins and cognitive decline in older persons. Neurology (2005) 2.11
Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol (2003) 1.89
Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.84
Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging (2008) 1.82
Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci (1998) 1.80
Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat (2005) 1.61
The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care (2010) 1.59
Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice. Brain Behav Immun (2009) 1.36
Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci (2008) 1.34
C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res (1997) 1.29
C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci (2006) 1.22
Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett (2008) 1.20
Association of C-reactive protein with cognitive impairment. Arch Neurol (2010) 1.19
Neuroinflammation and cognitive aging. Curr Psychiatry Rep (2010) 1.17
Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia. J Clin Exp Neuropsychol (1998) 1.12
Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10
Dissociations in hippocampal and frontal contributions to episodic memory performance. Neuropsychology (2005) 1.09
Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old. Alzheimers Dement (2009) 1.09
Leukoaraiosis severity and list-learning in dementia. Clin Neuropsychol (2009) 1.04
Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol (2008) 1.04
Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing (2007) 1.03
Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci (2005) 1.00
Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample. Psychosom Med (2009) 0.99
Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population. Neurosci Lett (2006) 0.93
Inflammatory response in Alzheimer's disease. Tohoku J Exp Med (1994) 0.93
Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc (2008) 0.93
Cognitive dysfunction with aging and the role of inflammation. Ther Adv Chronic Dis (2011) 0.92
Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer's disease. Psychopharmacology (Berl) (2009) 0.91
The dysexecutive syndrome associated with ischaemic vascular disease and related subcortical neuropathology: a Boston process approach. Behav Neurol (2010) 0.85
Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1. Prog Neurobiol (2009) 0.78
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature (2005) 8.55
The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol (2011) 8.15
Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol (2004) 7.07
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA (2005) 6.20
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA (2003) 5.23
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05
Hearing loss and cognitive decline in older adults. JAMA Intern Med (2013) 4.25
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain (2010) 3.84
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry (2010) 3.66
Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol (2003) 3.66
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry (2006) 3.61
Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2007) 3.61
A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study. J Am Geriatr Soc (2009) 3.58
Limited literacy and mortality in the elderly: the health, aging, and body composition study. J Gen Intern Med (2006) 3.51
Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 3.50
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2003) 3.20
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology (2005) 3.14
Patient and caregiver characteristics associated with depression in caregivers of patients with dementia. J Gen Intern Med (2003) 3.13
Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol (2005) 3.11
A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc (2003) 3.09
Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron (2012) 3.07
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol (2008) 2.96
The association between physical function and lifestyle activity and exercise in the health, aging and body composition study. J Am Geriatr Soc (2004) 2.93
Neuroanatomical correlates of behavioural disorders in dementia. Brain (2005) 2.92
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82
Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82
Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology (2006) 2.79
Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry (2003) 2.77
Unravelling Boléro: progressive aphasia, transmodal creativity and the right posterior neocortex. Brain (2007) 2.75
Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2006) 2.73
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol (2009) 2.68
Contribution of Alzheimer disease to mortality in the United States. Neurology (2014) 2.67
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci (2009) 2.60
Cognitive impairment in chronic kidney disease. J Am Geriatr Soc (2004) 2.50
Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol (2011) 2.46
High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Arch Gen Psychiatry (2010) 2.43
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol (2008) 2.41
Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology (2005) 2.39
Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol (2006) 2.38
Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol (2005) 2.36
Depression and risk of developing dementia. Nat Rev Neurol (2011) 2.31
Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program (2003) 2.30
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Structural anatomy of empathy in neurodegenerative disease. Brain (2006) 2.28
Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol (2006) 2.27
Adverse oral health and cognitive decline: the health, aging and body composition study. J Am Geriatr Soc (2013) 2.27
Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol (2013) 2.26
Heritability of lobar brain volumes in twins supports genetic models of cerebral laterality and handedness. Proc Natl Acad Sci U S A (2002) 2.24
Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res (2007) 2.19
Connected speech production in three variants of primary progressive aphasia. Brain (2010) 2.19
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Cognitive control, goal maintenance, and prefrontal function in healthy aging. Cereb Cortex (2007) 2.18
Promising strategies for the prevention of dementia. Arch Neurol (2009) 2.14
Diagnosis of human prion disease. Proc Natl Acad Sci U S A (2005) 2.13
Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. Arch Neurol (2003) 2.12
Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. Neuropsychology (2003) 2.11
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology (2007) 2.09
Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care (2012) 2.09
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain (2009) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med (2011) 2.07
Limited literacy in older people and disparities in health and healthcare access. J Am Geriatr Soc (2006) 2.06
The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med (2013) 2.05
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol (2007) 2.02
Functional connectivity tracks clinical deterioration in Alzheimer's disease. Neurobiol Aging (2011) 2.01
Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr (2007) 1.98